Anxiety and dysautonomia symptoms in patients with a NaV1.7 mutation and the potential benefits of low-dose short-acting guanfacineRita de Cássia Collaço, Frank Bosmans, Carley Blevins et al.|Clinical Autonomic Research|2023Cited by 9